Remission of refractory granulomatous primary cutaneous anaplastic large cell lymphoma to brentuximab vedotin

Appalanaidu Sasapu; Andrew L J Dunn; Jerad Gardner; Henry K Wong

doi:10.1136/bcr-2021-242896

Article info

Case report

Remission of refractory granulomatous primary cutaneous anaplastic large cell lymphoma to brentuximab vedotin

Authors

Appalanaidu Sasapu Medicine, Division of Hematology Oncology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA PubMed articles Google scholar articles
Andrew L J Dunn Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA PubMed articles Google scholar articles
Jerad Gardner Pathology, Geisinger Medical Laboratories, Danville, Pennsylvania, USA PubMed articles Google scholar articles
Henry K Wong Dermatology, University of Arkansas for Medical Sciences College of Medicine, Little Rock, Arkansas, USA PubMed articles Google scholar articles

Correspondence to Dr Henry K Wong; hkwong{at}uams.edu

View Full Text

Citation

Sasapu A, Dunn ALJ, Gardner J, et al

Remission of refractory granulomatous primary cutaneous anaplastic large cell lymphoma to brentuximab vedotin

BMJ Case Reports CP 2021;14:e242896.

Publication history

Accepted June 1, 2021
First published July 21, 2021.

Online issue publication

March 05, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password